• AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease 

      Strauss, Philipp; Marti, Hans-Peter; Furriol, Jessica; Nakken, Sigrid; Vidar, Beisvåg; Eikrem, Øystein Solberg; Beisland, Christian; Flatberg, Arnar; Bostad, Leif; Scherer, Andreas; Eleni, Skandalou (Journal article; Peer reviewed, 2021)
      Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and one of the most common cancers. While survival for localized ccRCC is good, the survival of metastatic disease is not, and ...
    • Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts 

      Kipp, Anne; Marti, Hans Peter; Babickova, Janka; Nakken, Sigrid; Leh, Sabine; Strøm Halden, Thea Anine; Jenssen, Trond; Vikse, Bjørn Egil; Åsberg, Anders; Spagnoli, Giulio; Furriol, Jessica (Journal article; Peer reviewed, 2023)
      Background Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM ...
    • A multiomics disease progression signature of low-risk ccRCC 

      Strauss, Philipp; Rivedal, Mariell; Scherer, Andreas; Eikrem, Øystein Solberg; Nakken, Sigrid; Beisland, Christian; Bostad, Leif; Flatberg, Arnar; Skandalou, Eleni; Beisvag, Vidar; Furriol, Jessica; Marti, Hans Peter (Journal article; Peer reviewed, 2022)
      Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of ...